![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07K 16/22 | (2006.01) |
A61K 39/395 | (2006.01) | ||
A61P 37/00 | (2006.01) |
(11) | Number of the document | 2528946 |
(13) | Kind of document | T |
(96) | European patent application number | 11701933.1 |
Date of filing the European patent application | 2011-01-28 | |
(97) | Date of publication of the European application | 2012-12-05 |
(45) | Date of publication and mention of the grant of the patent | 2016-11-16 |
(46) | Date of publication of the claims translation | 2017-01-25 |
(86) | Number | PCT/US2011/022810 |
Date | 2011-01-28 |
(87) | Number | WO 2011/094465 |
Date | 2011-08-04 |
(30) | Number | Date | Country code |
388697 P | 2010-10-01 | US | |
361687 P | 2010-07-06 | US | |
299801 P | 2010-01-29 | US |
(72) |
SKOKOS, Dimitris, US
|
(73) |
REGENERON PHARMACEUTICALS, INC.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Autoimuninių ligų gydymo būdai su DLL4 antagonistais |
METHODS OF TREATING AUTOIMMUNE DISEASES WITH DLL4 ANTAGONISTS |
Payment date | Validity (years) | Amount | |
2017-12-18 | 8 | 185.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2019-01-28 |